Exploring the Developmental Potential of Human Germinal Vesicle Oocytes Aiming at Fertility Preservation: Can We Increase the Yields of Competent Oocytes through IVM Combined with Vitrification?

The rescue in vitro maturation (rIVM) of germinal vesicle oocytes (GVs) has been proposed to improve the total number of mature oocytes in women undergoing fertility preservation. Currently, there is no consensus about the clinical utility of this practice, and heterogeneity in the protocols used may influence the final outcomes. This study investigated the developmental potential of mature metaphase II (MII) human oocytes obtained from GVs after rIVM and the impact of applying vitrification at different timepoints either before or after rIVM. After randomization, oocytes were assigned to undergo rIVM and thereafter vitrification or intracytoplasmic sperm injection (ICSI), or to undergo direct vitrification-warming and thereafter rIVM and ICSI. The likelihood of obtaining MII oocytes was just slightly higher in the fresh rIVM group compared to the vitrification-warming-rIVM group. When comparing fresh rIVM that underwent subsequently ICSI, the fertilization and developmental rates up to the blastocyst stage were seen to be reduced in both groups that underwent vitrification either before or after rIVM. Although some blastocysts were obtained in the fresh rIVM-ICSI group, the efficacy of these methods was low overall, suggesting that the further development of protocols for IVM conducted early after denudation is needed to improve the final results of rIVM aiming at fertility preservation.

[1]  R. Gilchrist,et al.  Perspectives on the development and future of oocyte IVM in clinical practice , 2021, Journal of Assisted Reproduction and Genetics.

[2]  Mingpeng Zhao,et al.  In vitro rescue immature oocytes – a literature review , 2021, Human fertility.

[3]  I. Peinado,et al.  Impact of Maturation and Vitrification Time of Human GV Oocytes on the Metaphase Plate Configuration , 2021, International journal of molecular sciences.

[4]  F. Amant,et al.  ESHRE guideline: female fertility preservation† , 2020, Human reproduction open.

[5]  R. Gilchrist,et al.  Live births after oocyte in vitro maturation with a prematuration step in women with polycystic ovary syndrome , 2020, Journal of Assisted Reproduction and Genetics.

[6]  Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. , 2019, Fertility and sterility.

[7]  R. Vassena,et al.  Could fertility clinics offer a sizable improvement of live birth rates by maturing post-GVBD oocytes in vitro? , 2019, Journal of Assisted Reproduction and Genetics.

[8]  W. Son,et al.  Immature Oocyte for Fertility Preservation , 2019, Front. Endocrinol..

[9]  F. Lundberg,et al.  A prospective study of women and girls undergoing fertility preservation due to oncologic and non‐oncologic indications in Sweden–Trends in patients’ choices and benefit of the chosen methods after long‐term follow up , 2019, Acta obstetricia et gynecologica Scandinavica.

[10]  K. Oktay,et al.  Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  P. Zhou,et al.  Gene expression profiling of human blastocysts from in vivo and ‘rescue IVM’ with or without melatonin treatment , 2017, Molecular medicine reports.

[12]  I. Peinado,et al.  Ultrastructural characteristics of human oocytes vitrified before and after in vitro maturation , 2017, The Journal of reproduction and development.

[13]  K. Chatzimeletiou,et al.  Vitrification of Human Germinal Vesicle Oocytes: before or after In Vitro Maturation? , 2017, International journal of fertility & sterility.

[14]  J. Remohi,et al.  Oocyte vitrification as an efficient option for elective fertility preservation. , 2016, Fertility and sterility.

[15]  T. Psaltopoulou,et al.  In Vitro Maturation in Women with vs. without Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis , 2015, PloS one.

[16]  G. Coticchio,et al.  Oocyte maturation: gamete-somatic cells interactions, meiotic resumption, cytoskeletal dynamics and cytoplasmic reorganization. , 2015, Human reproduction update.

[17]  N. Mahajan,et al.  Fertility preservation in female cancer patients: An overview , 2015, Journal of human reproductive sciences.

[18]  T. Haaf,et al.  Epigenetic disturbances in in vitro cultured gametes and embryos: implications for human assisted reproduction. , 2013, Fertility and sterility.

[19]  K. Oktay,et al.  Options on fertility preservation in female cancer patients. , 2012, Cancer treatment reviews.

[20]  K. Lundin,et al.  Atlas of human embryology: from oocytes to preimplantation embryos. Preface. , 2012, Human reproduction.

[21]  S. Nottola,et al.  The effect of immature oocytes quantity on the rates of oocytes maturity and morphology, fertilization, and embryo development in ICSI cycles , 2012, Journal of Assisted Reproduction and Genetics.

[22]  Seang Tan,et al.  Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. , 2010, Reproductive biomedicine online.

[23]  K. Oktay,et al.  In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. , 2010, Reproductive biomedicine online.

[24]  R. Chian,et al.  Fertility Preservation with Immature and in Vitro Matured Oocytes , 2009, Seminars in reproductive medicine.

[25]  P. Bacchetti,et al.  Sample size calculations in clinical research. , 2002, Anesthesiology.

[26]  G. Wright,et al.  Birth after cryopreservation of immature oocytes with subsequent in vitro maturation. , 1998, Fertility and sterility.

[27]  R. Shaw,et al.  Differential effects of cryopreservation on nuclear or cytoplasmic maturation in vitro in immature mouse oocytes from stimulated ovaries. , 1998, Human reproduction.

[28]  H W Jones,et al.  Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization. , 1983, Fertility and sterility.

[29]  Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. , 2019, Fertility and sterility.